Weerapatr Lokatekrawee — Driving patient access and go-to-market strategy across APAC and Europe for major therapeutic portfolios, powered by a technical background in digital innovation.

APAC & Europe
Patient Access
5+
Years Exp.

MSc &
BEng Hons
With over 5 years of experience spanning the pharmaceutical and tech-solutions sectors, I specialize in navigating complex regulatory environments, including NLEM/CSMBS submissions, and developing robust Go-To-Market strategies across APAC and Europe.
My work focuses on driving patient access for highly impactful portfolios including MASH, Cardiovascular, and Alzheimer’s therapies. Holding an MSc in Management of Information Systems from LSE and a 1st Class Honors degree in Industrial Engineering, I bridge the gap between technical infrastructure, business insights, and commercial growth.
Microsoft Imagine Cup National Finalist, TUBC Top 16, New Cambridge Writing Award
Experience in cross-functional projects across Thailand, Japan, and Northwest Europe
Leading strategic NLEM submissions for MASH and defining reimbursement pathways under CSMBS. Shaping launch strategies for cardiovascular and Alzheimer's portfolios, aligning inflammation narratives with RWE.
R3: Orchestrated sub-cutaneous Alzheimer's launch prep in Japan and Out-of-Pocket assessments in NW Europe. R2: Coordinated competitive intelligence globally and led CKD market research. R1: Designed Frontline Incentive Tools and implemented RPA for internal data management in Thailand.

Dissertation: Worth or worse: the influence of non-fungible tokens (NFTs) on the work of NFT creators. Coursework focused on Innovating Organizational IT and Socioeconomics of Digital Innovation.

Managed cloud partnerships with Alibaba and Huawei Cloud. Successfully managed the full sales cycle for large-scale B2B enterprise projects. Completed a high-intensity tech rotation at the Hong Kong HQ.
Key coursework in Operation Research, Risk Management, and Industrial Cost Analysis. Developed a comparative study for Flight Delays Prediction.

KPMG: Developed an internal Chatbot prototype increasing search efficiency 3x and conducted e-payment risk assessments. Siemens: Managed intranet renewal and migrated legacy data to a user-centric interface.
Looking to discuss pharmaceutical market access, technology strategies, or digital innovation? I'd love to hear from you.
Location